 Selverman B was found to be the most effective compound against a 549 lung cancer cells with an IC50 value of 19.2 muM. This compound also caused significant cell accumulation in the G2-M phase and reduced the number of cells in the G0-G1 phase. Therefore, Selverman B may be a promising candidate for future research into treatments for lung cancer. This article was authored by Shima Hashemi, Hassan Sarich, Rezy Kiani, and others.